Drug Approval | April 17, 2026
Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
The national platform brought together healthcare professionals, patient advocates, and stakeholders
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Former Wavemaker executive to lead media strategy and digital transformation agenda
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
Subscribe To Our Newsletter & Stay Updated
